海目星(688559.SH):今年一季度SE設備訂單約4億元,進入二季度以來保持良好的簽單趨勢
格隆匯5月23日丨海目星(688559.SH)於2023年5月19日召開股東大會交流,問答環節中,就“在光伏板塊,公司SE設備的簽單趨勢或者環比增速如何?產能是否能夠滿足?”,公司回覆稱,公司SE設備簽單情況良好,公司今年1季度該類設備訂單約4億元,進入二季度以來,該類市場需求仍然旺盛,保持良好的簽單趨勢。
作為平台型公司,海目星能夠整合集團資源,為猛增的市場需求做到及時響應,快速將光伏產能提升上來,以滿足訂單需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.